What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review
Erik Veskimäe(Tampere University), Éva Compérat(Vienna General Hospital), J. Alfred Witjes(Radboud University Nijmegen), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Estefanía Linares(Hospital Universitario La Paz), Yuhong Yuan(McMaster University), Richard Sylvester(European Organisation for Research and Treatment of Cancer), Shahrokh F. Shariat(Universitätszahnklinik Wien), H.M. Bruins(Radboud University Nijmegen)
Cited by 131
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688